Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List Additions and Request for Comments
FDA adds new harmful and potentially harmful constituents (HPHCs) to the established list, expanding reporting and testing requirements for tobacco product manufacturers, including e-liquids and ENDS. This may affect PMTA submissions and ongoing compliance obligations.
Aforeworn detected this change in the Vape & Tobacco Retail Compliance space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. E-liquid manufacturers, tobacco product manufacturers, importers, and any entity required to report HPHCs under PMTA or other FDA regulations. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No immediate deadline; however, any new PMTA submissions or annual reporting must include the new HPHCs. Existing PMTAs may need to be amended if the new constituents affect the product's harm profile.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Vape & Tobacco Retail Compliance continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA added new constituents to the HPHC list, meaning manufacturers must now test for and report these additional constituents in their products and in tobacco smoke.
Who it affects
E-liquid manufacturers, tobacco product manufacturers, importers, and any entity required to report HPHCs under PMTA or other FDA regulations.
What you must do
Review the new HPHC list, update testing protocols to include new constituents, and ensure any pending or future PMTA submissions include data on these constituents.
Deadline
No immediate deadline; however, any new PMTA submissions or annual reporting must include the new HPHCs. Existing PMTAs may need to be amended if the new constituents affect the product's harm profile.
Never miss a change like this again
Aforeworn watches Vape & Tobacco Retail Compliance around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Vape & Tobacco Retail Compliance
- US FDA proposes rule to tighten oversight of foreign tobacco makers - KELO-AM
- Heated tobacco: FDA renews IQOS exposure-modification authorization - Vera Health
- FDA Authorizes Modified Risk Claims for ZYN Nicotine Pouches: A Landmark Step for Tobacco Harm Reduction - The National Law Review
- FDA Finally Issues Proposed Rule to Require Foreign Tobacco Manufacturers to Register Facilities and List Products - Tobacco Reporter
- FDA Proposal Would Allow Oversight of Foreign Manufacturers - Tobacco Reporter